PCVX
Vaxcyte, Inc.Healthcare · $8.1B market cap
Verdict
We can't put a fair value on PCVX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow PCVX
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
1 of the investors we track holds PCVX. In Q2 2026, 1 added and 1 sold out. Who we track
Insider activity
Since Aug 31, 2026: no open-market purchases, 6 sales worth $376K and 18 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Wassil Jim
EVP, Chief Scientific Ofc, COO · 2026-09-09
Sold
$79K
Wassil Jim
EVP, Chief Scientific Ofc, COO · 2026-09-04
Sold
$84K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-01
Sold
$19K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-01
Sold
$56K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-01
Sold
$44K
Show all 6 salesShow fewer
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-01
Sold
$94K
Other filings
Wassil Jim
EVP, Chief Scientific Ofc, COO · 2026-09-08
Tax withholding
$330K
Cowan Elvia
SVP, Finance & CAO · 2026-09-08
Tax withholding
$80K
Dhaliwal Harpreet S.
Chief Technical Ops Officer · 2026-09-08
Tax withholding
$462K
GUGGENHIME ANDREW
PRESIDENT AND CFO · 2026-09-08
Tax withholding
$432K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · 2026-09-08
Tax withholding
$1.0M
Show all 18 other filingsShow fewer
Jodar Luis
Chief Medical Officer · 2026-09-04
Award
$5.4M
Jodar Luis
Chief Medical Officer · 2026-09-04
Award
52,632 shares
Cowan Elvia
SVP, Finance & CAO · 2026-09-02
Tax withholding
$20K
Dhaliwal Harpreet S.
Chief Technical Ops Officer · 2026-09-02
Tax withholding
$41K
GUGGENHIME ANDREW
PRESIDENT AND CFO · 2026-09-02
Tax withholding
$88K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · 2026-09-02
Tax withholding
$211K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-02
Tax withholding
$88K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-09-01
Option exercise
$12K
Cowan Elvia
SVP, Finance & CAO · 2026-08-31
Tax withholding
$15K
Dhaliwal Harpreet S.
Chief Technical Ops Officer · 2026-08-31
Tax withholding
$22K
GUGGENHIME ANDREW
PRESIDENT AND CFO · 2026-08-31
Tax withholding
$77K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · 2026-08-31
Tax withholding
$174K
Wassil Jim
CHIEF OPERATING OFFICER · 2026-08-31
Tax withholding
$77K
About Vaxcyte, Inc.
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works